Predict your next investment

Corporation
HEALTHCARE | Drug Development
drugdevelopment.labcorp.com

See what CB Insights has to offer

Founded Year

1997

Stage

Acq - P2P | Acquired

Valuation

$0000 

About LabCorp Drug Development

LabCorp Drug Development provides advanced drug, device, and diagnostic breakthroughs.

LabCorp Drug Development Headquarter Location

210 Carnegie Center

Princeton, New Jersey, 08540,

United States

609-452-8550

Latest LabCorp Drug Development News

2021 Key Players – Covance(Labcorp), Eurofins Global Central Library, ICON Central Labs, Medpace Reference Laboratory

Jan 14, 2022

2021 Key Players – Covance(Labcorp), Eurofins Global Central Library, ICON Central Labs, Medpace Reference Laboratory Pharmaceutical companies are seeking for ways to reduce cost of development and manufacturing their products. Central lab services are one of the most commonly outsourced services by these companies. Apart from reduced cost, the use of central labs also accelerates the drug development process. Central labs are generally fully outsourced by pharmaceutical and biopharmaceutical companies. Many CRO’s have become interested in central lab services, since they provide bundled services that allows them to take a broad range of services. Some of the key strategies that the central lab market players impose are, bundling services and adopting advance technology solutions. Due to large volume of clinical trial study data and increasing complexity, bundled services offers a variety of services to pharmaceutical and biopharmaceutical companies at a discounted rate. Furthermore, adoption of advance technology and software to automate some process, aids in reducing time duration for some services, thereby reducing the cost of the clinical trial. The pharmaceutical industry is evolving and strategic partnerships have become significantly more common across the industry. A number of companies sign multiyear, fixed price based service agreement with either a single central lab or multiple labs. For an instance, in 2016, Pfizer established relationship [p with its fourth strategic partner inventive Health. The company has already been in a partnership with ICON, Parexel and PPD. Thus central lab market is expected to grow at a significant rate owing to the increase in number and complexity of clinical trials, increase in prevalence of diseases and increasing need to reduce the cost of trails along with the rising trend of outsourcing across the world. Central Lab Market: Key Players There are a number of large players in the central lab market. Some of the players that offer central lab services include, Covance(Labcorp), Eurofins Global Central Library, ICON Central Labs, Medpace Reference Laboratory, PPD Central Lab and Q² Solutions among many others. To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9067 Central Lab Market: Drivers and Restraints Increase in the complexity of clinical trials and its environment has led to the emergence and growth of a number of central labs across the world. Increase in number of clinical trials, reduced cost of trials, advancement in new therapies and drugs are some of the factors that argument the growth of the central lab market. However, regulatory challenges may hinder the growth of the market during the forecast period. Central Lab Market: Overview Central Lab market is segmented into service type, end users and regions. Central lab service provides have a number of services that may be bundled or singular services. These services can be broadly categorized as genetic services, biomarker development services, microbiology services, histology services, specimen management and storage services, specialty chemistry services including coagulation, electrophoresis, liquid chromatography and toxicology among other services. Central Lab Market: Regional Outlook North America combined with Europe take the maximum share of the radiation protection market. This is due to advancement in technology, increased healthcare budget, rise in awareness, and increasing number of interventional cardiology procedures in the regions. However in regions such as China and India, the growing demand for interventional cardiology procedures, ageing population and limited number of healthcare professionals has created an opportunity for the growth of the Central Lab market in such regions. Thus, the Central Lab market is expected to grow with a significant CAGR in the APAC region. The report covers exhaustive analysis on: Central Lab Market Segments Eastern Europe (Poland, Russia) China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing LabCorp Drug Development

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LabCorp Drug Development is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

72 items

https://www.amdm.org/members.html

LabCorp Drug Development Patents

LabCorp Drug Development has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/12/2004

4/20/2010

Catheters, Fluid dynamics, Medical equipment, Implants (medicine), Aerodynamics

Grant

Application Date

3/12/2004

Grant Date

4/20/2010

Title

Related Topics

Catheters, Fluid dynamics, Medical equipment, Implants (medicine), Aerodynamics

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.